Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

April 1, 2018

Study Completion Date

April 1, 2018

Conditions
Hepatocellular CarcinomaHCCHepatitis CHCV
Interventions
BEHAVIORAL

Automated reminders

At the time consent is obtained, members of the research team will collect data about how a subject prefers to be contacted for automated reminders (i.e. text messages, postcard, email, MyChart)

BEHAVIORAL

Patient navigation

The patient navigator will attempt to provide a reminder to the subject one to three days before the scheduled imaging and also offer to accompany the subject to the test.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02833298 - Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening | Biotech Hunter | Biotech Hunter